Omega Medical Imaging

Company profile

About Omega Medical Imaging

Omega Medical Imaging is pioneering AI-enabled interventional imaging systems that fundamentally transform radiation safety in medical procedures. The company's flagship FluoroShield™ technology represents the first FDA-cleared AI-powered radiation reduction system for image-guided therapy procedures. By leveraging artificial intelligence to automatically detect the Region of Interest (ROI) during interventional cases, FluoroShield™ acts as a secondary collimator that reduces unnecessary radiation exposure to peripheral anatomy while maintaining pristine image quality. The company offers two primary product lines: Soteria.AI for cardiac interventions and E-View.AI for interventional endoscopy procedures. Both systems integrate seamlessly into clinical workflows, requiring no manual adjustments from practitioners. Clinical studies have demonstrated radiation dose reductions of up to 84% for both patients and staff across various procedure types and frame rates. The technology combines AI-driven ROI detection with ultra-fast collimation and advanced image processing, including proprietary TruBlock™ technology that concentrates imaging on critical areas while safeguarding surrounding anatomy. Omega Medical Imaging serves hospitals, health systems, and interventional labs performing high-volume cardiac catheterization and advanced endoscopy procedures. The company's mission centers on setting a new standard of care in interventional medicine by making procedures safer for patients who were previously considered too high-risk due to radiation concerns, including obese patients and those requiring complex interventions.

Company description · Omega Medical Imaging official website